Lactose (India) Reports Strong FY26 Financials and Merger Update

Revenue for FY 2025-26 reached Rs 163.29 crore, increasing from Rs 116.40 crore in the previous year. Net profit improved to Rs 6.06 crore compared to Rs 5.16 crore in FY 2024-25.

Reader Takeaway: Strong 40% top-line growth and NCLT merger approval are key, balanced by proposed higher director remuneration costs.

What just happened

Lactose (India) has released its Annual Report for FY 2025-26, highlighting a 40% jump in revenue from operations. The company also confirmed that the NCLT Ahmedabad Bench approved its scheme of amalgamation with Vitanosh Ingredients Private Limited on 5th August 2026.

Why this matters

The revenue growth signals operational scaling, while the NCLT approval marks a milestone in the company’s corporate restructuring efforts. Investors are now looking toward the upcoming Annual General Meeting (AGM) to weigh the impact of proposed governance changes, specifically the higher remuneration for the Managing and Whole-Time Directors.

Corporate Action Details

The board has proposed several special resolutions for the upcoming AGM on 30th September 2026:

• Remuneration Increase: A proposed hike to Rs 15 lakh monthly salary for MD Mr. Atul Maheshwari and Whole-Time Director Mrs. Sangita Maheshwari, effective 1st April 2026.
• Related Party Transactions: Seeking approval for transactions with 'AVA ARTIS' up to Rs 25 crore annually for the next three fiscal years.
• Audit Appointments: Mr. Alpesh A. Lakeshri has been proposed as the Cost Auditor for FY 2026-27.

What to track next

Shareholders should monitor the final integration steps of the Vitanosh Ingredients merger and the voting outcomes at the 30th September AGM regarding the proposed related-party transaction limits and executive compensation structures.